Skip to content
bioinnovationbeacon.com

bioinnovationbeacon.com

  • Home
  • AI
  • Biotech News
  • Research
  • Technology
  • Press Releases
  • Privacy Policy
  • Contact Us

Category: AriBio

CTAD 2026: AriBio’s Alzheimer’s candidate slows cognitive decline as monotherapy
AriBioResearch and Discovery

CTAD 2026: AriBio’s Alzheimer’s candidate slows cognitive decline as monotherapy

AriBio’s Alzheimer’s asset hit one of the dual endpoints in a Phase 3 trial, slowing cognitive decline by 31% when…

byadminNovember 17, 2026

| Depth News by Ascendoor | Powered by WordPress.